BioInvent granted patents for cancer programme

19-09-2016

BioInvent granted patents for cancer programme

Feng Yu / Shutterstock.com

Sweden-based pharmaceutical research company BioInvent International has been granted additional patent protection for its BI-505 immune oncology programme for myeloma.  


BioInvent International, myeloma, ICAM-1, cancer, Michael Oredsson, antibody cells, BI-505, patent

LSIPR